Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929

Nagla Abdel Karim, Jieling Miao, Karen L. Reckamp, Carl M. Gay, Lauren A. Byers, Ying‐Qi Zhao, Mary W. Redman, Daniel R. Carrizosa, Wei‐Lien Wang, W. Jeffrey Petty, Kathan Mehta, Bryan A. Faller, Edem Agamah, Samer S. Kasbari, Rajini Katipamula Malisetti, Atul Kumar, John M. Schallenkamp, Krishna Alluri, Jhanelle E. Gray, Karen Kelly